Surrozen, Inc. ( SRZN) - Stock Earnings
SRZN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -71.6 million USD | 983000 USD |
| 2025Q4 | -183.2 million USD | 528000 USD |
| 2026Q1 | -127.5 million USD | 5.0 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SRZN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -43.0 million USD | 12.5 million USD |
| 2024 | -63.6 million USD | 10.7 million USD |
| 2025 | -242.0 million USD | 3.5 million USD |
| 2026 Est. | — | — |
SRZN
Price: $24.57
52 week price:
Earnings Per Share: -36.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 41336
Market Capitalization: 348.1 million